Financial News
Biosyent Inc Ord (TSV:RX)
Price and Volume
Detailed Quote| Volume | 2,461 |
| Open | 16.62 |
| Bid (Size) | 16.61 (10) |
| Ask (Size) | 17.03 (3) |
| Prev. Close | 16.90 |
| Today's Range | 16.62 - 16.91 |
| 52wk Range | 10.65 - 17.50 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Performance
52-Week Range
3.3% below 52-week high
16.91
10.6552W Low
17.5052W High
1 Week
16.211W Low
16.911W High
Biosyent Inc Ord (RX) traded between $10.65 and $17.50 over the past 52 weeks and last traded at $16.91, 3.3% below its 52-week high. Over the past week it ranged between $16.21 and $16.91.
Past 12 Months
1W
+$0.18
1M
+$1.06
3M
+$2.19
6M
+$1.79
YTD
+$4.15
1Y
+$5.16
RX was +44.0% over the past year, +11.9% over six months, +32.6% year to date, +1.1% in the last week.
12 Months vs Market
RX
+44.0%
DIA
+9.8%
SPY
+15.0%
QQQ
+22.3%
IWM
+12.5%
Over the past 12 months RX returned +44.0% versus DIA (Dow) +9.8%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +22.3% and IWM (Russell 2000) +12.5%.
Volume & Liquidity
0.23× 3-mo avg
Today 2,461
3-mo avg 10.7K
1W
1.8K
1M
8.0K
3M
10.7K
6M
9.2K
YTD
7.8K
1Y
6.9K
RX most recently traded 2,461 shares against a 3-month average daily volume of 10.7K.
Frequently Asked Questions
Is Biosyent Inc Ord publicly traded?
Yes, Biosyent Inc Ord is publicly traded.
What exchange does Biosyent Inc Ord trade on?
Biosyent Inc Ord trades on the Toronto Venture Stock Exchange
What is the ticker symbol for Biosyent Inc Ord?
The ticker symbol for Biosyent Inc Ord is RX on the Toronto Venture Stock Exchange
What is the current price of Biosyent Inc Ord?
The current price of Biosyent Inc Ord is 16.91
When was Biosyent Inc Ord last traded?
The last trade of Biosyent Inc Ord was at 10/08/26 03:46 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
